💬 Thank you, ISPOR—The Professional Society for Health Economics and Outcomes Research for the posters, panels, and perspectives
Our team returns from ISPOREurope full of insights and gratitude.
■ Gratitude for the collaborative conversations, the thought-provoking sessions, and the many colleagues and clients we connected with in-person.
We especially appreciated discussions around:
• The evolving impact of EU JCA
• Linking RWE to sustainable access
• New perspectives on patient-centred value
• And the questions raised in every Q&A
📊 We were also proud to co-author three client-led posters presented at the conference, highlighting impactful research grounded in Nordic data:
🔹 Myelofibrosis treatment patterns in Denmark and Sweden
🔹 Glycaemic control and real-world costs in Swedish T2D
🔹 Long-term income impacts in working-age glioma patients
Special thanks to our colleagues from the athagoras Group, IGES Pharma, and IGES MedTech for the shared moments and meaningful exchanges throughout the week.
These collaborations are a reminder of how real-world evidence, done rigorously, supports better policy, access, and outcomes.
🤔 What topic or session stuck with you most from ISPOR?
